Clinical Trials Directory

Trials / Completed

CompletedNCT01125033

Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients

Efficacy of Vitamin C, Vitamin E and Their Combination for Treatment of Restless Legs Syndrome in Hemodialysis Patients: a Randomized Double-blind, Placebo-controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether vitamin C, vitamin E and their combination are effective in the treatment of RLS in hemodialysis patients.

Detailed description

RLS is a common problem in hemodialysis patients; 20 to 40% of hemodialysis patients suffer from RLS. Hemodialysis patients have a high oxidative stress status. Oxidative stress has been proposed to play an important role in the pathogenesis of RLS. Vitamin C and vitamin E are potent antioxidant agents that have already been shown to be effective in the treatment of periodic limb movement disorder (PLMD) in hemodialysis patients. PLMD is closely associated with RLS in hemodialysis patients. The aim of this study was to evaluate the efficacy of vitamin C, vitamin E and their combination in the treatment of RLS in hemodialysis patients.

Conditions

Interventions

TypeNameDescription
DRUGVitamin C & Vitamin EThe patients in this arm received one tablet of vitamin C (200 mg) and one capsule of vitamin E (400 mg) daily for 8 weeks
DRUGVitamin CThe patients in this arm received one tablet of vitamin C (200 mg) and one placebo capsule daily for 8 weeks.
DRUGVitamin EThe patients in this arm received one capsule of vitamin E (400 mg) and one placebo tablet daily for 8 weeks.
DRUGVitamin C Placebo & Vitamin E PlaceboThe patients in this arm received one placebo capsule and one placebo tablet daily for 8 weeks.

Timeline

Start date
2008-03-01
Primary completion
2009-01-01
Completion
2009-02-01
First posted
2010-05-18
Last updated
2011-06-17

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01125033. Inclusion in this directory is not an endorsement.